RING CHRISTINE (General Counsel) sold 16.9% of their position (5.39K shares) of NURIX THERAPEUTICS, INC. on the open market
Open‑market sale worth $90.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/1/2026ACC: 0001817199-26-000016
Officer· General Counsel
Since Jul 2020
-5.39K
Net shares
Net seller
$90.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.39K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.39K
Price / share
$16.76
Trade value
$90.41K
% of position
16.9%
5/1/2026
31.85K→26.45K
Total
Net shares
−5.39K
Net value
-$90.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | S · Sale | −5.39K | $16.76 | $90.41K | 16.9% | 31.85K | 26.45K |
| Total | −5.39K | -$90.41K | ||||||
Derivative Transactions0
No derivative transactions reported